These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 17063263

  • 1. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, Zheng W.
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 3. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM.
    Hum Mol Genet; 2006 Jan 01; 15(1):1-10. PubMed ID: 16306136
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S, Wagner K, Chang-Claude J, Hoffmeister M, Brenner H, Försti A.
    Cancer Detect Prev; 2007 Jan 01; 31(5):408-16. PubMed ID: 18031946
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C, Brisson J, Bérubé S, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr 01; 17(4):880-8. PubMed ID: 18398029
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K, Hemminki K, Israelsson E, Grzybowska E, Söderberg M, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A.
    Breast Cancer Res Treat; 2005 Jul 01; 92(2):133-40. PubMed ID: 15986122
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B.
    Cancer Res; 2003 Nov 15; 63(22):8051-6. PubMed ID: 14633738
    [Abstract] [Full Text] [Related]

  • 8. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1090-5. PubMed ID: 15894657
    [Abstract] [Full Text] [Related]

  • 9. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 15; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR, Kataoka N, Shu XO, Wen W, Gao YT, Cai Q, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2006 Nov 15; 15(11):2115-22. PubMed ID: 17119036
    [Abstract] [Full Text] [Related]

  • 11. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
    Johansson M, McKay JD, Rinaldi S, Wiklund F, Adami HO, Grönberg H, Kaaks R, Stattin P.
    Prostate; 2009 Sep 01; 69(12):1281-91. PubMed ID: 19455605
    [Abstract] [Full Text] [Related]

  • 12. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH, Hietala M, Henningson M, Olsson H, Jernström H.
    Breast Cancer Res Treat; 2011 Jun 01; 127(3):785-94. PubMed ID: 21140206
    [Abstract] [Full Text] [Related]

  • 13. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr 01; 16(4):763-8. PubMed ID: 17416768
    [Abstract] [Full Text] [Related]

  • 14. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2461-6. PubMed ID: 17164371
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
    Shin A, Ren Z, Shu XO, Cai Q, Gao YT, Zheng W.
    Breast Cancer Res Treat; 2007 Sep 01; 105(1):55-61. PubMed ID: 17066319
    [Abstract] [Full Text] [Related]

  • 17. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
    Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, Yu MC, Ingles SA.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 01; 14(1):144-51. PubMed ID: 15668488
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-1 receptor polymorphism and ischemic stroke: a case-control study in Chinese population.
    Cheng J, Liu J, Li X, Peng J, Han S, Zhang R, Xu Y, Nie S.
    Acta Neurol Scand; 2008 Nov 01; 118(5):333-8. PubMed ID: 18477064
    [Abstract] [Full Text] [Related]

  • 19. Association of genetic polymorphisms in the VEGF gene with breast cancer survival.
    Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q, Ruan ZX, Gao YT, Zheng W.
    Cancer Res; 2005 Jun 15; 65(12):5015-9. PubMed ID: 15958542
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
    Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, Gao YT, Zheng W.
    Clin Cancer Res; 2005 Feb 01; 11(3):1093-8. PubMed ID: 15709176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.